MarketPulse

royalty revenue

2 articles
The Motley FoolThe Motley Fool··Jonathan Ponciano

Ligand CFO Cashes In on 80% Rally; Strong Fundamentals Support Gain

Ligand Pharmaceuticals CFO Octavio Espinoza sold $688K in stock under a prearranged plan. The sale reflects portfolio diversification, not concerns, as the biotech firm posts strong 2025 results.
LGNDbiotechearnings growth
The Motley FoolThe Motley Fool··Eric Trie

Disciplined Growth Trims InterDigital After 70% Rally in Patent Licensing Play

Disciplined Growth Investors reduces InterDigital stake by $64.3M after 70% stock surge, trimming position from 4.95% to 3.71% of assets while maintaining $193.9M exposure.
IDCCSMCIEXEportfolio rebalancingintellectual property